Simbolo, Michele
Simbolo, Michele
DIPARTIMENTO DI DIAGNOSTICA E SANITA' PUBBLICA
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers
2019-01-01 Simbolo, M; Mafficini, A; Vicentini, C; Ruzzenente, A; Rusev, B; Brunelli, M; Pedron, S; Bertuzzo, F; Barbi, S; Fassan, M; Corbo, V; Bagante, F; Turri, G; Luchini, C; Lawlor, R; Guglielmi, A; Bassi, C; Scarpa, A
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models
2018-01-01 Gkountakos, A; Pilotto, S; Simbolo, M; Vicentini, C; Mafficini, A; Del Curatolo, A; Scarpa, A; Tortora, G; Corbo, V; Bria, E
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations
2018-01-01 Pilotto, S; Grizzi, G; Sperduti, I; Simbolo, M; Vicentini, C; Caliò, A; Caccese, M; Mafficini, A; Carbognin, L; Corbo, V; Gkountakos, A; Santo, A; Infante, M; Brunelli, M; Scarpa, A; Tortora, G; Bria, E
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT
2011-01-01 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Simbolo, Michele; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide